JPS5726244B2 - - Google Patents

Info

Publication number
JPS5726244B2
JPS5726244B2 JP13724373A JP13724373A JPS5726244B2 JP S5726244 B2 JPS5726244 B2 JP S5726244B2 JP 13724373 A JP13724373 A JP 13724373A JP 13724373 A JP13724373 A JP 13724373A JP S5726244 B2 JPS5726244 B2 JP S5726244B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP13724373A
Other languages
Japanese (ja)
Other versions
JPS5052220A (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00313431A external-priority patent/US3833725A/en
Application filed filed Critical
Publication of JPS5052220A publication Critical patent/JPS5052220A/ja
Publication of JPS5726244B2 publication Critical patent/JPS5726244B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP13724373A 1972-12-08 1973-12-07 Expired JPS5726244B2 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00313431A US3833725A (en) 1972-12-08 1972-12-08 Dialkylated glycol compositions and medicament preparations containing same
US41396573A 1973-11-08 1973-11-08

Publications (2)

Publication Number Publication Date
JPS5052220A JPS5052220A (enExample) 1975-05-09
JPS5726244B2 true JPS5726244B2 (enExample) 1982-06-03

Family

ID=26978866

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13724373A Expired JPS5726244B2 (enExample) 1972-12-08 1973-12-07

Country Status (6)

Country Link
JP (1) JPS5726244B2 (enExample)
CA (1) CA1043259A (enExample)
DE (1) DE2358644C3 (enExample)
ES (1) ES421299A1 (enExample)
FR (1) FR2209544B1 (enExample)
GB (1) GB1454109A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US9327060B2 (en) * 2009-07-09 2016-05-03 CARDINAL HEALTH SWITZERLAND 515 GmbH Rapamycin reservoir eluting stent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296515A (fr) * 1958-12-05 1962-06-22 Boehringer & Soehne Gmbh Procédé de fabrication de solutions de chloramphénicol dans des liquides aqueux
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets

Also Published As

Publication number Publication date
GB1454109A (en) 1976-10-27
DE2358644C3 (de) 1979-11-15
DE2358644A1 (de) 1974-07-04
ES421299A1 (es) 1977-05-16
CA1043259A (en) 1978-11-28
FR2209544B1 (enExample) 1978-03-24
FR2209544A1 (enExample) 1974-07-05
DE2358644B2 (de) 1979-04-05
AU6319173A (en) 1975-06-05
JPS5052220A (enExample) 1975-05-09

Similar Documents

Publication Publication Date Title
JPS4887533A (enExample)
FR2202404A1 (enExample)
FR2209544B1 (enExample)
JPS5224850B2 (enExample)
JPS5216455B2 (enExample)
JPS4882316A (enExample)
JPS4899838A (enExample)
JPS4888445A (enExample)
JPS5143956B2 (enExample)
JPS4990700U (enExample)
JPS4960049U (enExample)
JPS4910113U (enExample)
CH567507A5 (enExample)
CH564259A5 (enExample)
BG18632A1 (enExample)
CH571985A5 (enExample)
CH571289A5 (enExample)
CH570781A5 (enExample)
CH570610A5 (enExample)
CH570544A5 (enExample)
CH570525A5 (enExample)
CH571650A5 (enExample)
CH567383A5 (enExample)
CH567359A5 (enExample)
CH566897A5 (enExample)